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Hypervirulent Chlamydia trachomatis Clinical Strain Is a Recombinant
between Lymphogranuloma Venereum (L2) and D Lineages
Naraporn Somboonna,a* Raymond Wan,a David M. Ojcius,b Matthew A. Pettengill,b Sandeep J. Joseph,c Alexander Chang,d Ray Hsu,a
Timothy D. Read,c,d and Deborah Deana,e,f
Center for Immunobiology and Vaccine Development, Children’s Hospital Oakland, Research Institute, Oakland, California, USAa; Health Sciences Research Institute and
School of Natural Sciences, University of California, Merced, Merced, California, USAb; Department of Medicine, Division of Infectious Diseases, Emory University School of
Medicine, Atlanta, Georgia, USAc; Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USAd; Department of Medicine, University of
California, San Francisco, San Francisco, California, USAe; and Joint Graduate Program in Bioengineering, University of California, Berkeley, Berkeley, California, USAf
* Present address: Department of Microbiology, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.

Chlamydia trachomatis is an obligate intracellular bacterium that causes a diversity of severe and debilitating diseases worldwide. Sporadic and ongoing outbreaks of lymphogranuloma venereum (LGV) strains among men who have sex with
men (MSM) support the need for research on virulence factors associated with these organisms. Previous analyses have been
limited to single genes or genomes of laboratory-adapted reference strain L2/434 and outbreak strain L2b/UCH-1/proctitis. We
characterized an unusual LGV strain, termed L2c, isolated from an MSM with severe hemorrhagic proctitis. L2c developed nonfusing, grape-like inclusions and a cytotoxic phenotype in culture, unlike the LGV strains described to date. Deep genome sequencing revealed that L2c was a recombinant of L2 and D strains with conserved clustered regions of genetic exchange, including a 78-kb region and a partial, yet functional, toxin gene that was lost with prolonged culture. Indels (insertions/deletions)
were discovered in an ftsK gene promoter and in the tarp and hctB genes, which encode key proteins involved in replication, inclusion formation, and histone H1-like protein activity, respectively. Analyses suggest that these indels affect gene and/or protein function, supporting the in vitro and disease phenotypes. While recombination has been known to occur for C. trachomatis
based on gene sequence analyses, we provide the first whole-genome evidence for recombination between a virulent, invasive
LGV strain and a noninvasive common urogenital strain. Given the lack of a genetic system for producing stable C. trachomatis
mutants, identifying naturally occurring recombinants can clarify gene function and provide opportunities for discovering avenues for genomic manipulation.
ABSTRACT

IMPORTANCE Lymphogranuloma venereum (LGV) is a prevalent and debilitating sexually transmitted disease in developing

countries, although there are significant ongoing outbreaks in Australia, Europe, and the United States among men who have sex
with men (MSM). Relatively little is known about LGV virulence factors, and only two LGV genomes have been sequenced to
date. We isolated an LGV strain from an MSM with severe hemorrhagic proctitis that was morphologically unique in tissue culture compared with other LGV strains. Bioinformatic and statistical analyses identified the strain as a recombinant of L2 and D
strains with highly conserved clustered regions of genetic exchange. The unique culture morphology and, more importantly,
disease phenotype could be traced to the genes involved in recombination. The findings have implications for bacterial species
evolution and, in the case of ongoing LGV outbreaks, suggest that recombination is a mechanism for strain emergence that results in significant disease pathology.
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C

hlamydia trachomatis is responsible for a broad spectrum of
diseases in males and females of all age groups worldwide.
C. trachomatis is the leading cause of preventable blindness in
tropical developing countries and the leading global cause of bacterial sexually transmitted diseases (STDs) (1). Over 92 million
individuals are infected with C. trachomatis in the urogenital tract
annually (1). In the United States alone, more than 1 million cases
are reported each year, although the actual rates are estimated to
be 2.8 million due to the deficiencies in screening and reporting
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(2). The Centers for Disease Control and Prevention (CDC) have
reported that these infections result in an annual cost to Americans of over $10 billion.
The complications of urogenital infection include tubal factor
infertility, ectopic pregnancy, and chronic pelvic pain. The lymphogranuloma venereum (LGV) strains of C. trachomatis are considered biological variants of the organism and cause invasive disease such as genital ulcers, hemorrhagic proctitis, rectal fistulae,
and suppurative lymphadenitis (3). LGV is prevalent in develop-
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ing countries and represents a neglected tropical disease. To
date, five different strains of LGV have been identified: L1 to L3,
L2a, and L2b.
Infection is initiated at the mucosal epithelia by host cell endocytosis of the infectious but metabolically inert elementary body
(EB). Following cell entry, the EB expands into the replicative
form termed the reticulate body (RB) within a nonacidified inclusion. Over 30 C. trachomatis proteins are secreted into the membrane of the inclusion, including a family of inclusion proteins of
which IncA is the best described (4, 5). IncA is thought to be
critical for fusion of independent inclusions that form when more
than one EB enters the same host cell.
The mechanism for ascension to upper genital tract tissues
remains ill described. While LGV strains have not been identified
in endometrial or fallopian tube tissue, they are known to cause
ulceration, invade the basal layers, and travel via the lymphatic
system to regional draining lymph nodes (3). There have been
sporadic and ongoing outbreaks of LGV among men who have sex
with men (MSM) in many developed countries worldwide where,
historically, the rates of LGV have been extremely low. The first
reported outbreak occurred in Rotterdam, Netherlands, in 2003
(6). Additional outbreaks were reported to occur in the United
States, Europe, and Australia (7). The majority of these infected
men had engaged in high-risk behavior, were HIV positive, and
presented with painful hemorrhagic proctitis, discharge, and, in
some cases, constipation. There was a surprising absence of genital
ulcers and the inguinal syndrome.
In 2005, a novel LGV strain, termed L2b, which was associated
with both symptomatic and asymptomatic disease, was identified
(8); the genome was subsequently sequenced (9). While a similar
strain based on ompA genotyping was detected among isolates
dating back to the 1980s in San Francisco, CA (10), the degree of
genome homology between the two is not known. L2b strains have
also recently been reported to occur in urethritis cases (11). These
cumulative findings, especially the association of L2b with different disease presentations, and the availability of only two LGV
genomes (L2/434 and L2b/UCH-1/proctitis [9]), suggest that
further analyses of the morphological, molecular, and genetic
characteristics of clinical LGV strains are warranted to identify
virulence factors and understand the microbial nature of the outbreaks. The purpose of the current study was to advance these
objectives by characterizing the cellular biology and genomics of
an LGV isolate from an HIV-negative MSM who had severe hemorrhagic proctitis.
We isolated a unique LGV strain from the MSM that was discovered to be a recombinant of invasive L2 and noninvasive D
strains. We present the first computational and statistical wholegenome evidence for recombination in this pathogen. Our findings have implications for bacterial evolution and, in the case of
ongoing LGV outbreaks, suggest that recombination is a mechanism for strain emergence that results in significant disease pathology. While we do not know the molecular clock for these
events, the results suggest either that the recombinant was produced in the rectal mucosa of our patient prior to sampling or that
a clonal population of L2 and D recombinants had already
emerged and was circulating among the patient’s core sexual
group. Methods for direct genome sequencing of the organisms
present in various tissues will be required to fully ascertain the
diversity and recombinant nature of C. trachomatis strain infections and their associated disease phenotypes.
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RESULTS

Morphological characteristics of reference and clinical LGV
strains. We compared the morphological characteristics of reference strains D/UW3, L1/440, L2/434, L2a/TW-396, and L3/404,
clinical strain L2b, and a clinical isolate from the rectal mucosa of
an MSM from this study, termed L2c, in culture using HeLa229
cells and confocal fluorescence microscopy (see Materials and
Methods). Reference strains refer to C. trachomatis organisms that
were isolated many decades ago, have been propagated since then,
and are considered laboratory adapted. At 24 h, L2/434 (Fig. 1A)
and L1/440, L2a/TW-396, L3/404, and L2b (not shown) produced
large inclusions with IncA-containing fibers extending to secondary inclusions (Fig. 1A, arrowheads). D/UW3 had smaller inclusions than L2/434 at 24 h but a similar-sized inclusion at 48 h
(Fig. 1B), with IncA staining at all time points. In contrast, L2c
formed multiple smaller inclusions that did not fuse (Fig. 1C,
arrows); there was no evidence for IncA staining, IncA-containing
fibers, or fusion of inclusions during the course of development
at 12, 18, or 24 h for L2c (Fig. 1C and 1D) (data not shown for
12 and 18 h). We found that incA mRNA was expressed for strains
L2/434, D/UW3, and L2c (Fig. 1E), despite the absence of IncA
staining for L2c.
L2c was more difficult to grow and had 20% fewer infected and
surviving cells than LGV strains at 24 and 36 h with the use of the
same multiplicity of infection (MOI). The growth curve (Fig. 1F)
showed peak 16S rRNA relative expression at 24 h, with a taper to
36 and 48 h for L2. The peak was also at 24 h for L2c but was much
lower than for L2, while the peak for D/UW3 was at 48 h and lower
than for L2/434 but higher than for L2c.
Cytotoxic characteristics of reference LGV, reference
D/UW3, and clinical L2c strains. Because of the difference in
morphological characteristics between LGV and L2c strains and
previous reports of nonfusing strains being less virulent (12), we
hypothesized that other LGV strains would be more cytotoxic
than L2c. We also assayed the D/UW3 strain given the probability
that the partial toxin gene was acquired from a D strain (described
below). The cytopathic effects of each strain were determined by
infecting monolayers of HeLa cells with each strain independently
using a toxicity assay (see Materials and Methods). Infections were
visualized by light microscopy after 4 h. Surprisingly, the cellular
effects of L2/434 showed far less cytotoxicity (Fig. 2A) than those
of L2c (Fig. 2B) or D/UW3 (Fig. 2C), the latter two of which had
significantly higher numbers of cells that underwent rounding,
detachment, and lysis (score, 3⫹) than L2/434 (100% versus
⬍10%; P ⬍ 0.01 for both). By Western blot anlaysis, we show
toxin protein production for D/UW3 and L2c but not for L2
(Fig. 2G).
Comparative genomic analyses. Genomic DNA was extracted
from L2c grown in HeLa cells after plaque purification and propagation (13) (see Materials and Methods). To verify clonal purity,
ompA and MLST genes (14) for 10 clones were Sanger sequenced
following amplification by PCR and cloning using a TOPO TA kit
(Invitrogen, Carlsbad, CA) (see Materials and Methods). The sequences of the eight genes were identical for each clone.
Genome sequencing was performed using 454 pyrosequencing
(15). The genome sequences for the L2c chromosome (1,038,313
nucleotides [nt]) and plasmid (7,499 nt) were obtained following
assembly and in silico closure (see Materials and Methods). The
genome was annotated by the Integrative Services for Genomics
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FIG 1 IncA staining, incA mRNA expression, and inclusion morphology of D/UW3-, L2-, and L2c-infected HeLa229 cells. Cells were infected at an MOI of 1.0
and stained at 24 or 48 h as noted postinfection (see Materials and Methods). (A) L2/434. Green, IncA-specific monoclonal antibody (fluorescein-conjugated
secondary antibody); red, C. trachomatis-specific LPS monoclonal antibody (Cy3-conjugated secondary antibody); blue, DAPI (DNA). Arrowheads, IncAstained fibers to secondary inclusions. (B) D/UW3. Evidence for IncA at 48 h; staining as in (A). (C) There was no observed IncA staining for L2c. Arrows denote
multiple inclusions for a cell. Green, C. trachomatis-specific heat shock protein 60 monoclonal (fluorescein secondary antibody); red, IncA-specific monoclonal
(Cy3 secondary antibody); blue, DAPI. (D) L2c, same staining as for panel A, with no evidence of IncA. (E) incA mRNA expression. Cells were infected with
L2/434, D/UW3, or L2c at an MOI of 5, and total RNA was extracted at the designated time points. The graph represents the relative incA gene expression based
on quantitative real-time PCR of incA and 16S rRNA. Values represent the mean ⫾ standard deviation (SD) based on three independent experiments (see
Materials and Methods). (F) Growth curve. Cells were infected with L2/434, D/UW3, or L2c at an MOI of 1.0. Total RNA was harvested at designated time points
for quantitative PCR of C. trachomatis 16S rRNA. GAPDH was used for normalization. Values represent the mean ⫾ SD based on three independent experiments
(see Materials and Methods).

Analysis pipeline (16). There were 1,005 putative protein-coding
genes. While the overall sequence was similar to that of L2/434, we
noticed unusual patterns of localized variation. Using an in-house
program called Q-plotGenome (see Materials and Methods) and
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BLAST score ratio analysis (17), we identified a recombinant region of 78 kb and other smaller regions that were similar in sequence to D/UW3 (Fig. 3 and Table 1, region 1; see also Fig. S1 in
the supplemental material). Phylogenetic reconstructions (Fig. 4)
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FIG 2 Optical phase-contrast microscopy demonstrating different cytopathic effects and protein expression of L2/434-, D/UW3-, and L2c-infected HeLa229
cells. Cells were infected with an MOI of 100 and imaged at 4 hours postinfection. Experiments were performed in triplicate (see Materials and Methods).
(A) There were no cytopathic effects for L2/434 (original magnification, ⫻400). (B) A significantly higher number of cells with rounding, detachment, and lysis
were observed for L2c (original magnification, ⫻400). (C) The findings for D/UW3 were similar to those for L2c as shown in panel B (original magnification,
⫻400). After prolonged passage (see Materials and Methods), the cytopathic effects of L2c were lost (E) in comparison to those for D/UW3 (F). The morphology
now resembled that of L2/434 (D). (G) Toxin protein expression demonstrated by Western blot analysis. D/UW3, L2c, and L2/434 were grown in HeLa cells at an
MOI of 100, purified, run on a precast 4 to 12% gel, transferred to a PVDF membrane, and reacted with polyclonal antiserum against recombinant CT166 (see
Materials and Methods). Lanes represent purified EBs. Both D/UW3 and L2c showed strong reactivity to a protein at ~73 kDa that is close to the predicted
74.8 kDa size of CT166; there was no protein expression for L2/434.

confirmed the recombinant regions to have originated recently
from an ancestor similar to D/UW3, while the rest of the chromosome and plasmid were closely related to L2 sequences. Using
Q-plotGenome, we identified indels for the cytotoxin region, the
tarp and hctB genes, and the intergenic region (IGR) upstream of
the ftsK gene (Fig. S1).
A puzzling feature of the recombinant regions was a persistent
background of reads with bases similar to those of L2/434. We
plotted the number of nucleotide variants at each of the 7,982
single nucleotide polymorphisms (SNPs) between D/UW3 and

L2/434 (see Materials and Methods). At 6,527 (82%) of the known
SNP positions, all nucleotide reads had the L2/434 variant base
rather than that of D/UW3. At the other 18% of the known SNP
positions, D-like variants were either approximately 50% or significantly above zero (Fig. 3, red bars, and Table 1, regions 2, 3, 5,
and 6). It is probable that these SNPs were introduced through
gene conversion of localized segments with a D-like ancestor. The
Circos plot highlights candidate recombinant regions of L2c that
match to D/UW3 or L2/434 sequences (Fig. 5). A further 235 variant positions in two regions were not known variants between

FIG 3 Plot of the sequence read variation within the L2c chromosome. The x axis shows the coordinates of the L2c consensus sequence; the y axis shows the level
of 454 read coverage, expressed as the number of reads per base; the gray line is a smoothed curve of overall read redundancy (produced using the R “lowess”
function, with the f smoothing parameter set to 0.2). Red bars indicate the number of variant reads that match D/UW3 at the 7,982 known SNP positions between
D/UW3 and L2/434. Blue bars indicate all variant positions within the assembly that do not coincide with D/UW3 SNP but that may represent an outlying strain
within the D cluster. The horizontal bars represent the recombination regions defined in Table 1, including the location of the chromosomal partial toxin
insertion (region 4) and the hctB deletion (region 5).
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TABLE 1 Seven putative recombinant regions in clinical strain L2c
Region
1

L2c coordinatesa
53700–65500

2

65500–139200

3

301100–304500

4

510400

5

373606–374061

6

829000–855400

7

1019400–1019700

a
b
c
d

Gene(s)
CTL2c_349–475
(sufB)
CTL2c_475-1002

Polymorphism level (%)
15–25

Strain of origin
Unknown

Notes

70–90

D

CTL2c_838
(glgB)
Intergenic
(CT166)b
498
(CT046)c
CTL2c_920
(omcB-secD)
CTL2c_125

30–50

D

0b

D

Includes 16S rRNA operon,
tsK, and IGR upstream of ftsK
Deletion specific to L2 in
membrane thiol protease
Toxin gene insertion

100

NAd

Deletion in hctB

30–50

D

15

Unknown

Includes CT456/CTL2c_721
(tarp gene)
Homolog of TTSS
secreted protein CT621

Approximated to the nearest round hundred.
Although the genome sequence did not contain the partial cytotoxin gene, the initial plaque-purified isolate (prior to further propagation) did contain the gene.
The CT designation refers to the gene locus for D/UW3 genome.
NA, not applicable; there was no source strain because this was an intrinsic deletion.

L2/434 and D/UW3 (Fig. 3, blue bars, and Table 1, regions 1 and 7)
and may have arisen through recombination with a strain significantly different from D/UW3 or with a D strain that has variant
sequences in those regions. However, comparison of L2c with another D strain that was recently genome sequenced [D(s)/2923;
GenBank accession no. NZ_ACFJ00000000] (18) showed similar
results. The distribution of SNPs was almost identical to that for
D/UW3 (see Fig. S2 in the supplemental material). In fact, fewer
D(s)/2923 SNPs match (7,565 SNPs, versus 7,982 for D/UW3).
The likely explanation for these results is that an L2 strain acquired DNA segments from a D strain and either one other C. trachomatis strain or a D strain variant through gene conversion in
the patient. The patterns of SNP discovery could not have been
produced by accidental mixing of strain D and L2 genomic DNA
in the laboratory before genome sequencing. If that were the case,
all D-like SNPs would have had the same frequency in the chromosome and plasmid. Instead, more than 80% of the SNPs were
not seen at all, and 18% of the variants were found at frequencies
of greater than 15%. Furthermore, the extent of recombination
and conservation of the recombinant regions would have had to
have occurred in relatively few culture generations along with
elimination of any contaminating D or other donor strains, since
donor strains were not seen even with high-redundancy sequencing (75-fold). Also, all SNPs between L2c and L2/434 were within
the boundaries of the seven discrete recombinant regions (Table 1). Outside these regions, there was no intrinsic genetic variation in the genome backbones of L2c and L2/434-LGV strains isolated in California more than 30 years apart (10). Finally, all 10
plaque-purified clones screened by ompA and typed by multilocus
sequence typing (MLST) as L2 had no minor contaminating base
peaks.
Analyses of recombinant regions. As described above, we
identified seven putative recombinant regions within the L2c genome (Table 1). The regions were independently analyzed and
confirmed using Sanger sequencing (see Materials and Methods).
Region 1 contained SNPs in ~20% of the reads that match a
mixture of D-like and non-D-like variants, suggesting that the
DNA source was not a D strain. Comparison of L2c with D(s)/
2923 also did not reveal a match in this region. However, since
only two D strains [reference D/UW3 and clinical D(s)/2923] have
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been genome sequenced to date and the distributions of SNPs are
almost identical to each other, it is possible that other strains
within the D cluster may match this region.
In region 2, from the middle of the sufB gene, the proportion of
reads with SNPs rose to 70 to 90% for variants entirely D-like,
continuing for 78 kb and including a 16S rRNA operon. The ftsK
gene, a complement gene involved in cytokinesis, was in this region, reading from the 3=-to-5= side of the genome origin of replication. The IGR sequence upstream of ftsK was annotated using
the Bacterial PROMoter and BDGP programs; two putative promoters were identified at alignment coordinates 45 to 168 and 310
to 484, respectively, upstream of the start codon (see Fig. S3 in the
supplemental material). Both predictions had significant scores. A
33-nt deletion in the promoter at nt 406 was present for L2c,
D/UW3 and ocular strains compared to what was observed for
L2/434 and L2b/UCH-1/proctitis (Fig. S3), although the significance of these findings in terms of gene regulation is unknown.
Region 3 was a small recombinant region centered on the glgB
gene, part of the glycogen biosynthetic pathway.
Region 4 contained a large insertion of 1,915 nt representing a
partial toxin gene (CT166 in D/UW3) at the 5= end not present in
any LGV strains (Fig. 6). ClustalW alignment revealed that the
region of CT165 to CT168 was almost identical to that of D/UW3.
In vitro experiments revealed expression of the toxin with a cytotoxic phenotype in HeLa cells for L2c (Fig. 2B) but not for the
other LGV strains (Fig. 2A) (see Materials and Methods). After 20
passages of L2c in tissue culture, the toxin insertion was lost. The
cytotoxicity assay was repeated for the passaged isolate, and there
was no observed cytopathic effect for L2c (Fig. 2E) (see Materials
and Methods) or L2 (Fig. 2D); D/UW3 maintained a cytotoxic
effect (Fig. 2F). However, other genes that could have contributed
to the change in phenotype may have also been lost.
Region 5 contained a deletion of 216 nt (72 amino acids) located in a region of the hctB gene, which encodes a histone H1-like
protein, Hc2, and differentiates ocular, noninvasive, and LGV disease groups from one another (19, 20) (see Fig. S4 in the supplemental material). Compared to LGV strains, D/UW3 and D(s)/
2923 have a 20-amino-acid indel, while ocular strains have a 56amino-acid deletion (Fig. S5). The basic amino acids arginine and
lysine (Fig. S5, blue and purple letters), as well as pentapeptide
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FIG 5 Circos plot mapping of the consensus L2c sequence against L2/434 and
D/UW3. The figure highlights candidate recombinant regions of L2c that
match to D/UW3 or L2/434. Mapping was performed using 100-nt windows;
sequence comparisons used BLAST score ratio (see Materials and Methods).
Note that the coordinates of the D/UW3 genome follow the original GenBank
accession number and do not start at the origin of replication as for L2/434 and
L2b/UCH-1/proctitis. Fragments of L2c that have a stronger match to L2/434
are shown in grey; those in red have a stronger match to D/UW3. The inner
track with purple and orange bands represents protein-coding genes on the
negative strand (purple) and positive strand (orange). The figure was produced using Circos software, a tool for graphical representation of genome
data (58).

FIG 4 Phylogenetic comparison of the 75-kb recombinant region and a
random 75-kb region of the L2c chromosome. The trees for the major recombinant region (coordinates 65K to 140K) (A) and a random region of the
chromosome of the same 75-kb size (coordinates 500K to 575K) (B) are
shown. Colors denote disease grouping: yellow, trachoma; pink, invasive urogenital disease; blue, noninvasive urogenital disease. The trees were calculated
from MUSCLE alignments using the PHYLIP programs DNApars, Seqboot,
and Consense; 1,000 bootstrap replicates were performed to determine the
significance of the support for each node in the tree (see Materials and Methods). The Chlamydia muridarum Nigg (Ng) strain was used as the outgroup
(GenBank accession no. AE002160). All other C. trachomatis strains are described in the text except for the Sweden strain (Swed; GenBank accession no.
FN652779).

6

®

mbio.asm.org

motifs (e.g., TAARK, VAAKK, and TVAKR), are highly repetitive
(Fig. S5, red stars, denoting separation of pentapeptides) and consist primarily of three aliphatic residues followed by two basic
residues.
Region 6 contained two in-frame deletions in the tarp gene,
which encodes the translocated actin-recruiting phosphoprotein
TARP (21), at residues 379 to 687 and at residues 1084 to 1239,
based on the alignment with L2/434 (see Fig. S6 in the supplemental material). Both deletions are similar to D/UW3 and represent
areas of sequence divergence from LGV strains (Fig. S6). The deletion might have occurred from a crossover event, as suggested by
SimPlot informative sites and phylogenetic and bootscan analyses
(Fig. 7A to D) (see Materials and Methods). With the use of SimPlot, recombination breakpoints were located at residues 990 to
991 and 1218 to 1219, equivalent to residues 996 to 997 and 1689
to 1690 when gaps are included (Fig. 7B and C; Fig. S6).
The deletions represent an area of tyrosine-rich repeats in Tarp
(21). While L2/434 and L2b/UCH-1/proctitis contain six tandems
of tyrosine-rich repeat regions, L2c, A/2497, B/HAR36, C/TW3,
and D/UW3 contain three partial tandems of tyrosine-rich regions (see Fig. S7, purple letters, tyrosine in bold, in the supplemental material). Other polymorphisms include indels, SNPs,
and C-terminal repeat regions in B/HAR36, C/TW3, and D/UW3
that differentiate these strains from L2/434, L2b/UCH-1/proctitis,
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FIG 6 Schematic alignment of the toxin loci for clinical strain L2c and reference strains. Reference strains C/TW-3, H/UW4, D/UW3, and L2/434 and
clinical strain L2c were aligned using ClustalW. The toxin loci span genes
CT165 to CT168, although only CT166 is considered the toxin B-related protein. The other genes represent hypothetical proteins of unknown function.
The white boxes show the intergenic regions (IGRs). The grey rectangles represent the genes but are not drawn to scale. Dashed lines represent indels.

and L2c (Fig. S7, cyan and grey highlights, respectively). No polymorphisms in the proline-dense and actin-binding domains were
identified.
Region 7 contained non-D-like SNPs at a frequency of 10 to
20% of the total reads. Comparison of D(s)/2923 with L2c in this
region showed similar results.
Other significant individual L2c genes. Although neither IncA
expression nor large fused inclusions were observed in vitro for L2c
(Fig. 1), all LGV strains, including L2c, had identical incA sequences (data not shown). The promoter region encompassing
1,500 nt upstream of the incA start codon showed a high degree of
sequence conservation, with ⱖ99% nucleotide identity among
reference strains A to K, Ba, Da, Ia, Ja, and L1 to L3 and clinical
strains, L2b and L2c but not with D(s)/2923. Moreover, the promoter and encoding sequences of five hypothetical proteins
(CTL0475 to CTL0540) in L2/434, which might function like IncA
proteins due to the characteristic IncA protein domains and family, were also highly conserved (data not shown).
The sequence of the L2c ompA gene differed from the L2/434
sequence in an SNP upstream of variable segment 4 (VS4) that is
conserved among L2b/UCH-1/proctitis and L2= (see Fig. S8 in the
supplemental material). The mutation results in a synonymous
codon change.
DISCUSSION

The last decade has seen a cumulative increase in the evidence for
recombination and horizontal gene transfer (LGT) among intracellular bacteria, and Chlamydia has been no exception to this (14,
22–31). Data on recombination for C. trachomatis have come
solely from extensive comparative analyses of multiple genes dispersed throughout the genome for reference and clinical strains.
However, the authors of two recent publications of different
C. trachomatis clinical isolates that were genome sequenced concluded that there were regions of the genomes that were consistent
with interstrain recombination (9, 18). Here, we provide the first
analytically confirmed whole-genome evidence for recombination between C. trachomatis strains and, surprisingly, between invasive (LGV) and noninvasive urogenital strains. This provokes a
reassessment of how we think about C. trachomatis infections and
their evolution in vivo. We know that there are many diverse microbes that inhabit the rectum. However, it has not been considered that C. trachomatis strains coinfect the rectal mucosal with
any relevant frequency, unlike the urethra or cervix (32), and undergo LGT to produce recombinants.
Our study was also informative in showing how laboratory
processing of C. trachomatis strains after isolation from the patient
skewed understanding of the nature of the infection. Initially, the
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FIG 7 SimPlot representation and maximum chi-square analyses of putative
recombinant crossover regions in the tarp gene for clinical strain L2c compared
with those of parental strains L2/434, L2b/UCH-1/proctitis, and D/UW3. The outgroup was the collective sequence of the ocular strains A/2497, B/HAR36, and
C/TW3, as they were identical for this gene. (A) The number of informative sites
shared by the recombinant L2c tarp gene sequence with parental LGV (green) and
D/UW3 (red) tarp gene sequences is shown. The ocular outgroup is denoted in
blue. Note that L2c is more similar to D in the first ~996 bp and to LGV strains in
the middle ~800 bp but similar again to D for the remainder of the gene. (B) The
similarity plot is shown using the L2c tarp gene sequence as the query sequence in
comparison with those of the LGV (green), ocular group (blue), and D/UW3 (red)
strains (similarity score on the y axis). (C) The bootscan analyses are shown,
with percent similarity and phylogenetic relatedness (percentage of permuted
trees on the y axis), with significance of support for each node in the tree
between recombinant and parental sequences as denoted by the colors. (D)
The phylogenetic reconstructions are shown for each region bounded by recombination breakpoints supporting each crossover along with the results for
1,000 bootstrap replicates as supported by the analysis represented in panel C.
Left tree, base pairs 0 to 996; middle tree, base pairs 997 to 1689; right tree, base
pairs 1690 to 3735. See Materials and Methods.

L2c culture exhibited toxicity to HeLa cells and expressed the toxin
protein. In addition, an intact D-like toxin gene was recovered by
PCR and Sanger sequencing of the L2c genome. These data sug-
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gested a correlation with the clinical severity of disease. After multiple passage in cell culture, the cytotoxic phenotype was lost
(Fig. 2), likely representing selection against the cytopathic clone
in culture, and we could not detect the toxin gene in the genome
sequencing project using the passaged isolate. The conclusion
from this experience is that ideally, in order to fully grasp the
complexity of C. trachomatis infections, including the frequency
and diversity of recombinants, techniques for direct genome sequencing (without prior amplification) of the organisms present
in infected tissue will be needed.
IncA is an important constituent of the inclusion membrane,
facilitating the fusion of inclusions within the cell. Variants of
C. trachomatis strains B, D to H, Ia, and J that completely lack incA
or lack a portion of the gene produce multiple inclusions that do
not fuse (5, 33). The possible benefits of fusogenic inclusions include interaction with host cell vesicle trafficking and genetic exchange between the DNA from different RBs (4), although it has
been reported that nonfusogenic strains can undergo recombination (18), as has been demonstrated in vitro between nonfusogenic
and wild-type strains (27). Interestingly, patients infected with
naturally occurring incA “knockouts” or mutants have fewer signs
and symptoms, lower proliferative capacity, and fewer inclusionforming units (IFUs) in culture than wild-type fusing strains (12).
L2c failed to express IncA at any time during development and
produced many small nonfusogenic inclusions (Fig. 1). In contrast to the majority of asymptomatic cases caused by other nonfusogenic strains (12), L2c was hypervirulent in terms of clinical
signs and symptoms, producing severe hemorrhagic proctitis, although the patient did not exhibit an inguinal syndrome, which
may in part be due to the presence of a functional cytotoxin
(Fig. 2) (discussed below). The L2c sequence of incA was identical
to that of L2/434, and incA mRNA expression levels were similar
for both strains (Fig. 1E), which suggests that there may be a disruption in regulation for protein processing. Recent studies of the
transcription expression profile and cell culture kinetics of naturally occurring IncA knockout and wild-type strains suggest that
the IncA-negative phenotype may arise from multistep events,
involving a decrease in transcription level and/or a partial or complete inactivation of translation (5). Alternatively, host environmental clues may be necessary for regulation, as has been discovered for certain proteins among other human Gram-negative
pathogens, such as Burkholderia (34).
While the genomes of C. trachomatis strains to date are relatively conserved and share a high degree of synteny, an exception
to this is found in the plasticity zone (PZ) (28). The PZ is typically
rich in heterogeneity, with evidence for genome rearrangement as
well as LGT for many bacterial species, including Bartonella grahamii, Helicobacter pylori, and Shigella flexneri (28, 35–37). The
chlamydial PZ contains metabolic and virulence factors associated
with tissue tropism and immune evasion, including the toxin loci
(38, 39). Here, we consider it likely that the partial toxin gene was
acquired from coinfection with a D strain, since no LGV sequences (n ⫽ 6) to date contain a partial or complete toxin gene.
Indeed, D strains are prevalent in rectal infections among MSM. A
recent study in Sweden of C. trachomatis infections among 197
MSM identified high prevalences of strains G (45%), D (27%),
and J (26%) in the rectum (40), although there was no information on the presence of mixed infections or coinfection with LGV
strains. Importantly, the genomic uptake of DNA by transformation can occur during coinfection or sequential infection (41).
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Transformation is a likely mechanism employed by C. trachomatis, which would provide vast opportunities for genetic exchange.
We also found that the toxin acquired by L2c was functional
(Fig. 2). In our cytotoxicity assay, L2c had a profound effect on cell
morphology and death, as did D/UW3, compared with L2/434.
This effect was similar to that noted previously for strain D (42).
The C. trachomatis toxin is known to play an important role in
damaging host cell actin microfilaments, likely facilitating growth
of the intracellular inclusion (38, 42). Analyses of the toxin loci of
Chlamydia muridarum, a mouse pathogen, have suggested that
the toxin may function during an early phase of infection to inactivate GTPase near sites of EB entry, resulting in innate immune
evasion (28, 39). Consequently, introduction of the functional
toxin into L2c may support a mechanism for survival through
escaping immune surveillance and allowing sufficient replication
in nonfusing inclusions to cause severe localized mucosal disease
as in our patient. Moreover, the relatively high degree of cytotoxicity may result in barriers to dissemination to regional lymph
nodes and, thereby, a lack of an inguinal syndrome. While L2c
does not appear to be more cytotoxic than D/UW3, some degree
of cytotoxicity may limit the ability to successfully culture these
and other strains with a partial or complete toxin gene, which
could potentially hinder our abilities to detect emerging LGV
strains that contain the toxin and to further characterize them.
Tarp is secreted via the type III secretion system (TTSS), present in both EBs and RBs (43), at sites of entry into the host cell for
purposes of pathogen-directed actin polymerization and cytoskeleton rearrangement, an event that coincides with EB entry into the
cell (44). While the L2c tarp gene sequence alignment and phylogenetic tree imply a close genetic relationship with L2/434 and
L2b/UCH-1/proctitis strains, L2c contains a large in-frame deletion. Based on our analyses, the L2c tarp gene is likely a recombinant of L2 and D strains (Fig. 7).
According to functional studies of the chlamydial Tarp protein
(21), tyrosine phosphorylation has been associated with actin recruitment and inclusion development, while the number of
tyrosine-rich repeat regions has been associated with functionality. But inhibition of Tarp tyrosine kinase activity had no effect on
EB entry (21). Thus, the presence of only two partial and two
complete regions of tyrosine-rich repeats in the L2c Tarp, compared to six complete regions in other LGV strains (see Fig. S7 in
the supplemental material), would not prevent pathogen entry
but might affect cytoskeletal rearrangement that could impair inclusion development and result in smaller inclusions, as observed
for L2c (Fig. 1C). If this is found to be a common recombinant
region for clinical strains, it would highlight an evolutionary
mechanism for diversifying the number of tyrosine residues to
affect intracellular growth and infection outcomes. Indeed, recent
sequence analysis of the tarp gene from numerous clinical strains
found mutations that were similar among strains causing the same
disease, and phylogenetic analysis suggested that this is one of the
few genes that are responsible for C. trachomatis-specific disease
phenotypes (45). Inferior actin recruitment may also be correlated
with a lack of IncA expression and function, which would affect
inclusion fusion as in L2c.
During the late stage in the developmental cycle, C. trachomatis
expresses two histone H1 homologues that are involved in RBto-EB transition through nucleoid compaction and downregulation of gene expression (19, 46). As shown in Fig. S5 in the
supplemental material, the molecular mass and repetitive penta-
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peptide motifs of Hc2 are inversely correlated with the size of the
deletion; thus, there are variable numbers among the C. trachomatis strains (19, 20). The deletion in L2c Hc2 resulted in a substantial decrease in pentapeptide motifs and also in the number of
positively charged amino acids in two-thirds of the Hc2 amino
terminus. According to in vitro studies showing the DNA-binding
activity of L2/434 Hc2 expressed in Escherichia coli (20), the lower
number of repetitive motifs in L2c Hc2 may weaken electrostatic
and hydrogen-bonding interactions of Hc2 with DNA, which may
affect transcriptional regulation. Moreover, while ocular and
D/UW3 strains contain a proline at coordinate 153 (Fig. S5, denoted in bold and underlined), which creates a “kink” in protein
structure allowing Hc2 to participate in stronger interactions (20,
47), the lack of proline in L2c Hc2 (P153T) suggests weaker DNAbinding activity. Consequently, inefficient repression of gene expression would likely impede RB-to-EB differentiation and may
in part explain the poor propagation rate and morphological characteristics of L2c in culture.
A significant fraction of C. trachomatis genomes have unknown function, and the implied function of many genes is based
on sequence similarity to homologous genes from other prokaryotes and a few eukaryotes. While there have been numerous
attempts to produce stable mutants of C. trachomatis without success (48), which has hindered our ability to obtain unambiguous
information about gene function, the discovery of naturally occurring recombinants, such as L2c, can help clarify the functional
importance of specific genes and disease phenotypes and pave the
way towards identifying the underlying mechanisms of LGT for
developing a gene transfer system for Chlamydia.
MATERIALS AND METHODS
Clinical sample source. The study was approved by the Institutional Review Board of Children’s Hospital and Research Center at Oakland in
accordance with the Declaration of Helsinki. The clinical sample was obtained from the rectal mucosa of a male who had a history of sex with men
and presented with severe hemorrhagic proctitis. Briefly, a 26-year-old
male presented to a San Francisco Bay area clinic with a complaint of
severe rectal pain with blood on defecation. He described a series of encounters with homosexual men and unprotected anal receptive intercourse during the prior month until the onset of rectal pain 5 days prior to
the clinic visit. The rectal bleeding had commenced 1 day earlier. The man
had a history of gonorrhea in the past but no other known STDs, no
known exposure to men with known STDs, and no history of illicit drug
use. He was reported to be HIV negative and had no other medical conditions, was not on any over-the-counter or prescription medications,
and appeared to be in excellent health. On the physical exam, he was a
well-appearing male, afebrile, and normotensive, with no evidence for an
ulcerative lesion on the glans or shaft of the penis and no inguinal adenopathy. The anus was inflamed, and on proctoscopy, there was
extensive bleeding of the mucosa, with evidence of a purulent discharge.
Four swabs from each quadrant of the rectum were obtained and placed in
transport medium. Three swabs were sent to the clinical laboratory for
standard detection of Neisseria gonorrhoeae by commercial PCR and culture and of C. trachomatis by commercial PCR. The fourth swab was sent
to the Chlamydia Research Laboratory at CHORI for in-house C. trachomatis culture.
C. trachomatis strains and plaque assay. Reference strains D/UW3,
L1/440, L2/434, L2a/TW-396, and L3/404 (49), a clinical L2b strain from
Amsterdam (a kind gift from Servaas Morré), and the clinical sample,
referred to as L2c, from the above-described case, were analyzed. Each
strain was propagated in the human cervical adenocarcinoma cell line
HeLa229 using our previously described protocols (13, 50, 51). The clinical sample was diluted and directly plaque purified using sequential
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plaque purifications per our referenced protocols (13, 50, 51). To verify
the clonal purity of the plaques, ompA and MLST genes (14) were amplified by PCR and cloned separately using a TOPO TA cloning kit (Invitrogen) (52); 10 clones of each were randomly selected for Sanger sequencing
using techniques we have described previously (24). The confirmed clonal
plaques were then individually propagated in tissue culture. A total of two
passages were performed for L2c to generate sufficient gDNA for genome
sequencing. The EBs for each C. trachomatis isolate were purified from
contaminating human cells using DNase treatment followed by gradient
ultracentrifugation, and genomic DNA was purified from each isolate
using a High Pure PCR template preparation kit (Roche Diagnostics, Indianapolis, IN) as we previously described (13, 53).
For determination of MOI based on IFUs, duplicate serial 10-fold
dilutions of purified EBs were used to infect HeLa cells in 24-well plates.
After 24 to 48 h, the cells were fixed in methanol, washed with phosphatebuffered saline (PBS), and stained using the Pathfinder Chlamydia culture
confirmation monoclonal antibody (MAb) (Kallestad Diagnostics,
Chaska, MN) in accordance with the manufacturer’s directions. The
number of IFUs per well was divided by the number of cells per well; an
average was taken for duplicate wells to arrive at the MOI per strain.
Morphological characterization, incA expression, and growth
curve. HeLa cell monolayers grown in minimal essential medium (MEM)
containing 10% fetal bovine serum (UCSF Cell Culture Facility, San Francisco, CA) and 1 g/ml gentamicin (MP Biomedicals, Solon, OH) at a
confluence of 80% on 12-mm coverslips (Fisher Scientific, Pittsburgh,
PA) in 24-well plates were infected with either reference strains L1/440,
L2/434, L2a/TW-396, L3/404, and D/UW3, clinical strain L2b from Amsterdam, or the clinical strain L2c from this study in sucrose-phosphateglutamine (219 mmol/liter sucrose, 3.82 mmol/liter KH2PO4, 8.59 mmol/
liter Na2HPO4, 4.26 mmol/liter glutamic acid, 10 g/ml gentamicin [MP
Biomedicals], 100 g/ml vancomycin [Acros Organics, Morris Plains,
NJ], and 25 U/ml nystatin [MP Biomedicals] in distilled water, pH 7.4) at
an MOI of 1, unless indicated, for 2 h on an orbital shaker at room temperature. The inocula were aspirated, and the infected monolayers were
cultured in a humidified incubator at 37°C with 5% CO2 in Dulbecco’s
modified MEM (Cellgro, Manassas, VA) with GlutaMAX-1 (Life Technologies, Rockville, MD) supplemented with 10% fetal bovine serum
(UCSF Cell Culture Facility), 0.45% glucose solution (Cellgro), 20 mM
HEPES (UCSF Cell Culture Facility), 0.08% NaHCO3, and 1 g/ml cycloheximide (13). At 12, 18, 24, 36, and 48 h (48 h for D/UW3 only)
postinfection, the coverslips were fixed with methanol for 10 min, rinsed
in PBS, and incubated for 30 min with anti-C. trachomatis specific lipopolysaccharide (LPS) MAb (Virostat, Portland, ME) and anti-IncA MAb
3H7 (gift from Daniel D. Rockey) or polyclonal anti-IncA (gift from Ted
Hackstadt). The secondary antibodies were Cy-3 conjugated IgG (Jackson
ImmunoResearch, West Grove, PA) for LPS and fluorescein isothiocyanate (FITC)-labeled IgG (Jackson ImmunoResearch) or Alexa 488 (Invitrogen) for IncA and chlamydial heat shock protein 60. DAPI (4=,6diamidino-2-phenylindole dihydrochloride) (Vector Laboratories,
Burlingame, CA) was used to stain DNA. The inclusions formed by the
reference LGV and D/UW3 strains and the clinical L2c strain were visualized on a Zeiss 510 confocal microscope. Light microscopy was used to
examine the D/UW3, LGV, and clinical L2c strains at 36 h, but no inclusions were observed for any LGV strains at this time point.
We examined incA expression using our previously described techniques, with slight modifications (54, 55). HeLa cells were infected at 0, 2,
12, 24, and 48 h with D/UW3, L2/434, and L2c at an MOI of 5. Total RNA
was extracted using an RNeasy minikit (Qiagen, Valencia, CA) per the
manufacturer’s instructions; on-column DNase (Qiagen) treatment was
performed to remove contaminating DNA. cDNA was generated from
2 g of total RNA using TaqMan reverse transcriptase (RT) reagents and
random hexamers (Applied Biosystems, Foster City, CA). Quantitative
real-time PCR was performed in replicate using SYBR green chemistry,
reagents, primers (see Table S1 in the supplemental material), thermocycling, and standard curves as we previously described (54, 55). 16S rRNA
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was used for normalization. Negative controls and the standard curves for
each gene were used as previously described (54, 55). Analysis of the dissociation curves was used to verify the specificity of the amplified products. The conversion of the mean threshold cycle values determined the
relative amounts of target and control gene from the respective standard
curve. Three independent experiments were performed.
Growth curves for strains D/UW3, L2/434, and L2c were generated
using quantitative PCR as we previously described (52, 56). Briefly, each
strain at an MOI of 1 was grown in HeLa cells and harvested at 0, 12, 18, 24,
36, and 48 h, and total RNA was extracted and reverse transcribed as
described above. Each quantitative PCR consisted of 1⫻ SYBR green master mix (Applied Biosystems), 1 l of cDNA, and 5 pmol of each primer
(16S rRNA and glyceraldehyde-3-phosphate dehydrogenase [GAPDH] as
described in reference 56) in a total reaction volume of 25 l run on an
ABI 7900 (Applied Biosystems) using our thermocycling profile as previously described (56); standard curves were generated, and negative controls for each primer pair were included in each run as we previously
described (56). GAPDH was used for normalization. Melting curves were
used to verify the specificity of the reactions and the absence of primer
dimmers. Samples were amplified in triplicate where the mean was used
for analysis. Three independent experiments were performed.
Cytotoxicity assay. Reference strains D/UW3 and L2/434 and the clinical L2c strain from this study were analyzed in a cytotoxicity assay adapted
from the method of Belland et al. (42). HeLa cells were grown to 80%
confluence as described above in 24-well plates. The monolayers were
treated with 1 ml DEAE-dextran (45 g/ml) in Hanks’ balanced salt solution (HBSS) for 15 min at 37°C. The cells were infected at an MOI of 100
(~5 ⫻ 107 IFU) with each strain and mock infected in duplicate at room
temperature for 4 h on an orbital shaker. The inocula were removed, and
the cells were washed with HBSS and incubated for an additional 4 h in
growth medium as described above except for the addition of 10 g/ml
gentamicin (MP Biomedicals), 25 g/ml vancomycin (Fisher) to prevent
any nonchlamydial bacterial growth. The monolayers were visualized under light microscopy at ⫻400 magnification. The cells were scored for
rounding, detachment, and lysis compared to the levels for uninfected
control cells by the following metric: (⫺), same as cell control; 3⫹, 100%
of cells affected; 2⫹, 75% of cells affected; and 1⫹, 25% of cells affected.
The above-described experiments were repeated using 1 g/ml of
doxycycline to pretreat cells before infection. In addition, the assay was
repeated using L2/434 and a higher passage number (passage no. 20) for
L2c. A total of two independent experiments were performed for each of
these studies.
To detect the toxin protein, a Western blot analysis was performed as
we have previously described, with modifications (55). Briefly, L2/434,
D/UW3, and L2c were independently grown in HeLa cells as described
above at an MOI of 100. Purified EBs from each isolate were solubilized in
Laemmli buffer, run on NuPAGE Novex 4 to 12% bis-Tris precast gels
(Invitrogen) with a BenchMark prestained protein ladder (Invitrogen),
and electrophoretically transferred onto a BioTrace polyvinylidene difluoride (PVDF) membrane (Pall Life Science, Port Washington, NY) at
120 V for 2 h in 1⫻ NuPAGE transfer buffer (Invitrogen) with 10% methanol. The membrane was incubated with 5% skim milk in 1⫻ Trisbuffered saline (TBS) and 0.1% Tween 20, washed with 1⫻ TBS-0.1%
Tween 20, and reacted overnight with a polyclonal antiserum against recombinant CT166 (gift from Harlan Caldwell) at a 1:500 dilution. The
membrane was washed, and secondary antibody (goat anti-rabbit IgG
conjugated to horseradish peroxidase [HRP]; Bio-Rad, Hercules, CA) was
applied at a 1:1,000 dilution, incubated at room temperature, and washed
in 1⫻ TBS prior to detection using the SuperSignal West Pico chemiluminescent substrate (enhanced chemiluminescence [ECL] detection system; Thermo Scientific, Rockford, IL) and CL-XPosure Film (Thermo
Scientific).
Genome sequencing and assembly. The purified genomic DNA from
the clinical case was shotgun sequenced using a combination of the 454/
Roche GS-FLX Titanium and GS Junior instruments (454 Life Sciences,
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Branford, CT). The 809,874 reads were generated with an average read
length of 404 nt. Preliminary analysis suggested an unusually high proportion of contamination of DNA from the HeLa cell culture. Therefore,
618,844 reads of human origin were removed (identified by mapping to
the hs19 golden path release of the genome [http://genome.ucsc.edu/cgi
-bin/hgGateway]) using Newbler gsMapper 2.5 software.
We assembled a random subset of 50,000 of the remaining reads de
novo using the 454 gsAssembler software program, version 2.0.01.14, with
default parameters. The order of the contigs in the final genome sequence
was determined using a combination of the possible connections between
contigs suggested by overlapping reads (57) and information from mapping contigs against the L2/434 reference genome (9). After determination
of the correct path through the contig graph, the contigs were assembled
to form the final sequence. To accomplish this, the ends of adjoining
contigs were matched using BLAST (58) against the database of reads.
Reads found in both contigs were assembled into a consensus sequence
that bridged the two contigs to form a single, larger contig. The majority of
gaps were small enough to be spanned by a single read. The plasmid was a
single contig with reads overlapping the beginning and end, indicating the
expected circular redundancy.
For verification of the sequences, we aligned the original reads to the
consensus chromosomal and plasmid templates using gsMapper 2.3;
91.6% of the 191,030 human screened reads (average length, 436 nt)
mapped to the chromosome, and 6.8% mapped to the plasmid. The remaining unmapped reads were found not to assemble de novo into any
contigs consisting of more than 2 reads, suggesting that these were mostly
contamination that had not matched the human reference sequence. The
mapped assemblies were inspected to remove a small number of errors.
The final assembly, with an average redundancy of coverage of approximately 75-fold, was used for annotation. The identity of each base in the
final consensus sequence was determined by majority vote. The gsMapper
software revealed two possible structural variants in a minority of sequence reads. The first was a deletion between coordinates 133542 and
155549 present in 4 sequence reads. The second was a deletion between
bases 849581 and 849942 present in 19 sequence reads.
Genome annotation. The L2c consensus chromosome and plasmid
sequences were annotated automatically using the Integrative Services for
Genomics Analysis pipeline (16). Promoter 2.0 prediction (http://www
.cbs.dtu.dk/services/Promoter/), Bacterial PROMoter prediction (http:
//www.softberry.ru/berry.phtml), and the Berkeley Drosophila Genome
Project neural network (http://www.fruitfly.org/seq_tools/promoter
.html) were used to identify the ftsK putative promoter region, including
the initiation site, ⫺10 and ⫺35 promoter elements, and ribosome binding sites. The default parameters were used for prediction scores for significance.
Verification of indels. To verify the regions of diversity (L2-D hybrids), single amplicons of these regions (the tarp gene, incA, hctB, and
toxin locus genes; the IGR upstream of ftsK) that were identified by the
SAS program Q-plotGenome (see below) and genomic analyses (see below) as divergent from L2/434 were amplified, cloned using a TOPO TA
cloning kit (Invitrogen), and Sanger sequenced using primers (see Table S1 in the supplemental material) designed to amplify and sequence the
full length of each as previously described (16). Ten clones were sequenced for each. The sequences were compared with those of the following available reference strains (GenBank accession numbers are given in
parentheses): A/2497 (EU121607), B/HAR36 (EU121608), C/TW3
(EU121609), D/UW3 (AE001273), L2/434/Bu (AM884176), and L2b/
UCH-1/proctitis (AM884177) for the tarp gene; A/HAR13 (CP000051),
B/Jali20/0T (FM872308), C/TW3 (EU121596), D/UW3 (AE001273), L2/
434/Bu (AM884176), and L2b/UCH-1/proctitis (AM884177) for hctB;
A/HAR13 (CP000051), B/TW5 (DQ064209), B/TZ1A828/OT
(FM872307), Ba/Apache-2 (DQ064210), C/TW3 (DQ064211), D/UW3,
E/Bour (DQ064214), F/IC-CAL3 (DQ064215), G/UW57 (EU247624),
H/UW4 (EU247625), i/UW12 (DQ064218), Ia/870 (DQ064219),
J/UW36 (DQ064220), K/UW31 (DQ064221), L1/440 (DQ064222), L2/
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434/Bu, L2b/UCH-1/proctitis, and L3/404 (DQ064224) for incA; C/TW3
(AY647994), D/UW3, H/UW4 (AY647999), and L2/434 for the cytotoxin
locus; and A/HAR13, B/Jali20/0T, D/UW3, L2/434, and L2b/UCH-1/
proctitis for the IGR upstream of ftsK.
Comparative genomics and phylogenetic analysis. To detect recombination, we developed a program called Q-plotGenome that was written
as a set of macros in the SAS software 9.2 language (SAS Institute, Inc.,
Cary, NC) to compare the genome sequences of L2c with those of reference strains L2/434 and D/UW3. The core of the program is similar to that
of SimPlot (59) except that it covers the entire 1-Mb genome instead of a
discrete sliding window of limited size; it samples a series of fixed-length
subsequences (windows) from one genome and then compares them to
windows from the other genome. Q-plotGenome is, thus, a tool for comparing DNA sequences in the range of 1 Mb plus and for displaying results
graphically. The description of Q-plotGenome is detailed in Text S1 in the
supplemental material.
To identify statistically significant recombination breakpoints or regions,
SimPlot software 3.5.1 (http://sray.med.som.jhmi.edu/SCRoftware/) was
utilized as we have previously described (25). The parameters included a
window size of 200 base pairs (bp), a step of 20 bp, neighbor-joining trees
calculated using the Kimura-2-parameter distance model (60), and 1,000
bootstrap replicates to determine confidence for each branch (Fig. 7).
For a global analysis, we used a version of the BLAST score ratio approach (17) to identify recombinants. We aligned the databases of
both (i) raw L2c sequences and (ii) 100-nt windows along the L2c chromosome sequence separated by 50 nt against the L2/434 genome as a
reference and the other complete genomes listed in the previous section.
Matches with a BLAST score ratio of ⬍0.95 were plotted using Circos
software (Fig. 5) (61).
For analysis of specific regions, nucleotide sequences were aligned by
ClustalW 1.8, MUSCLE (62), or MAUVE (63). Gaps were removed using
GBLOCKS (64) with default parameters. Phylogenic inference and tree
plotting were performed using the MEGA 3.1 (65) package described
previously (13, 24, 25) or PHYLIP (66) programs DNApars, Seqboot, and
Consensus. Neighbor-joining trees were calculated using the Kimura
2-parameter model that assumes constant nucleotide frequencies and
their rates of substitution among sites (60) and 1,000 bootstrap replicates.
For detection of strain D-specific SNPs within the L2c data, we first
identified SNPs between the D/UW3 and L2/434 genomes using the
show-snps tool of the MUMmer package (67). We then mapped L2c
against L2/434 using gsMapper 2.3 and extracted the number of “D”-like
and “L2”-like nucleotides at each variant position from the 454AllDiffs.txt
output using a custom script. Similar analyses were performed for D(s)/
2923.
Nucleotide sequence accession numbers. The complete chromosome and plasmid sequences were submitted to the NCBI GenBank database (accession no. CP002024). The NCBI genome project identification
number is 47581. The raw data from the 191,030 human screened L2c
reads were deposited in the NCBI short read archive (sra; accession no.
SRP002231). The sequence of the L2c toxin gene from the initial plaque
purification was submitted to GenBank (accession no. 2981755).
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